Quarterly report pursuant to Section 13 or 15(d)

FAIR VALUE MEASUREMENT (Tables)

v3.22.1
FAIR VALUE MEASUREMENT (Tables)
6 Months Ended
Mar. 31, 2022
Fair Value Disclosures [Abstract]  
The following table sets forth by level within the fair value hierarchy the Company’s derivative financial instruments that were accounted for at fair value on a recurring basis as of September 30, 2021 and March 31, 2022, respectively:

The following table sets forth by level within the fair value hierarchy the Company’s derivative financial instruments that were accounted for at fair value on a recurring basis as of September 30, 2021 and March 31, 2022, respectively:

 

Description  

Quoted Prices in

Active Markets
for 

Identical Assets
(Level 1) 

   

Significant
Other

Observable
Inputs
(Level 2)

   

Significant Other

Unobservable

Inputs
(Level 3)

    Total Fair
Value as of
 
Derivative Financial Instrument at September 30, 2021   $       $ (1,201,656 )   $       $ (1,201,656 )
                                 
Derivative Financial Instrument at March 31, 2022   $     $ (1,385,887 )   $     $ (1,385,887 )
The change in derivative financial instruments for the six months ended March 31, 2022 is as follows:

The change in derivative financial instruments for the six months ended March 31, 2022 is as follows:

 

September 30, 2021 balance   $ (1,201,656 )
New derivative instruments issued      
Derivative instruments extinguished      
Change in fair value     (184,231 )
March 31, 2022 balance   $ (1,385,887 )